Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Irritable Bowel Syndrome (IBS) Clinical Trials

A listing of Irritable Bowel Syndrome (IBS) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (50) clinical trials

Diet Reintroduction Study in Irritable Bowel Syndrome

Research Plan Design: Blinded FODMAP reintroduction study Duration of study: 1 year Patient population: Eligible IBS patients Visit 1 (-2 weeks): After providing written informed consent, baseline and descriptive data will be obtained including age, sex, race, pertinent medical history, prior IBS treatments, vital signs, weight, use of concurrent medications ...

Phase N/A

Symptom Management for Irritable Bowel Syndrome

The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.

Phase N/A

The Multi-disciplinary Treatment of Functional Gut Disorders Study

Randomised controlled trial comparing standard outpatient clinic treatment with multi-disciplinary clinic treatment for functional gastrointestinal disorders. Patients will be followed up to end of clinic treatment and 12 months beyond the end of treatment. Symptoms, quality of life, costs to the healthcare system and psychological outcomes will be assessed.

Phase N/A

Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children

There is growing concern with recurrent radiation exposure particularly from routine radiologic modalities in children, this is especially relevant in pediatric Crohn's Disease in so far as CT entercolysis abdomen and small bowel series are often seen as complementary. Although small bowel series is accepted as a routine diagnostic modality ...

Phase N/A

Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disease (GI) affecting 10% -20% of the population and is composed of abdominal pain/discomfort, in combination with alterations of the stool habit. This is a functional disorder prevalent in Italy with double percentages in urban areas (13.7%) compared to rural ones (5.9%). ...

Phase N/A

Effects of Open-label vs Double-blind Treatment in IBS

The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.

Phase N/A

L. Casei DG in Patients With Irritable Bowel Syndrome.

To assess the effect of L. casei DG (Lactobacillus paracasei CNCMI1572; Enterolactis plus) on abdominal symptoms and gut microbiota metabolism/composition in non constipated patients with IBS (Irritable Bowel Syndrome). Patients will be randomized to receive L. casei DG capsules, b.i.d. for 12 weeks the a 4 weeks Follow Up period ...

Phase N/A

Effect of Diet on Gulf War Illness

Study Design This will be a prospective, blinded randomized clinical trial with two parallel groups. There will be 1-week screening period, 3-week diet treatment and, follow-up one month later while Veterans choose their own diet. Veterans who were deployed and served in Operation Desert Storm and Desert Shield will be ...

Phase N/A

Clinical and Molecular Phenotyping in IBD

Inflammatory bowel disease (IBD) and psoriasis (Ps) are common, chronic, immune- mediated barrier diseases with shared inflammatory pathways. Current therapeutic interventions with anti-cytokine antibodies (TNF-, IL-23/IL-12) reflect the intent to disrupt specific pathways of inflammatory immunopathology. Individual responses to biological treatment can be thereby be exploited in a systems biology ...

Phase N/A

Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain

Children with irritable bowel syndrome (IBS) or other pain-related functional gastrointestinal disorders (FGIDs) such as functional abdominal pain (FAP) represent a considerable part of visits to pediatric practitioners. These disorders do not only decrease the quality of life but also increase the risk of symptom persistence and comorbid mental issues ...

Phase N/A